North American High-Performance Liquid Chromatography (HPLC) market was valued at $2,076.4 million in 2025 and is projected to reach $3,165.2 million by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). Strong pharmaceutical and biopharmaceutical research and development activity in North America remains a foundational driver of this market growth. In the US, total research and development expenditure reached approximately $722 billion in 2023, marking a continued increase in corporate investment toward discovery and analytical innovation. Within this business, R&D spending, manufacturing industries, including pharmaceuticals and medicines, accounted for a significant portion, demonstrating high R&D intensity and commitment to drug and biologic development.

Indian HPLC market was valued at $174.2 million in 2025 and is expected to reach $180.1 million by 2035, expanding at a CAGR of 4.2% during the forecast period (2026–2035). The rapid expansion of India’s biopharmaceutical and biosimilar sectors is significantly boosting demand for advanced analytical tools such as HPLC, which are critical for impurity profiling, peptide and protein quantification, and complex molecule characterization. India’s vibrant biotechnology ecosystem, comprising thousands of biotech companies and startups, reflects the country’s evolution into a global innovation hub, which in turn fuels growth in biopharmaceutical R&D and quality control applications requiring HPLC systems.

global Osteoarthritis Therapeutics market was valued at $11,200.0 million in 2025 and is projected to reach $24,744.3 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026-2035). The growing burden of arthritis-related disability is a critical driver shaping demand in the osteoarthritis therapeutics market, as functional impairment significantly increases the need for sustained medical intervention. According to the US Centers for Disease Control and Prevention, an estimated 58.5 million adults aged 18 years and older in the US have arthritis, underscoring the scale of the affected population. Of these individuals, 25.7 million report arthritis-attributable activity limitations, reflecting substantial disease impact on daily functioning and quality of life. 

High-Performance Liquid Chromatography (HPLC) market was valued at $5,572.7 million in 2025 and is projected to reach $8,360.3 million by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). Recent technological advancements in the high-performance liquid chromatography (HPLC) market are centered on improving analytical performance, throughput, and ease of use. Manufacturers have introduced ultra-high-pressure liquid chromatography (UHPLC) systems capable of faster separations with higher resolution and lower solvent consumption compared with traditional HPLC platforms. New column chemistries, such as core-shell and superficially porous particles, are enhancing peak capacity and sensitivity for complex sample matrices across pharmaceutical, environmental, and food testing labs.

global Osteoarthritis Therapeutics market was valued at $11,200.0 million in 2025 and is projected to reach $24,744.3 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026-2035). The growing burden of arthritis-related disability is a critical driver shaping demand in the osteoarthritis therapeutics market, as functional impairment significantly increases the need for sustained medical intervention. According to US Centers for Disease Control and Prevention, an estimated 58.5 million adults aged 18 years and older in the US have arthritis, underscoring the scale of the affected population. Of these individuals, 25.7 million report arthritis-attributable activity limitations, reflecting substantial disease impact on daily functioning and quality of life. 

ASEAN e-commerce logistics market was valued at $4.8 billion in 2025 and is projected to reach $17.1 billion by 2035, growing at a CAGR of 13.4% during the forecast period (2026–2035). The rapid acceleration of mobile-led e-commerce adoption across ASEAN economies, particularly in Indonesia, Vietnam, Thailand, and the Philippines, is directly strengthening demand in the ASEAN e-commerce logistics market by driving higher order volumes and delivery frequency. Rising smartphone penetration and expanding access to digital payment platforms have supported sustained growth in daily active users on shopping and marketplace applications across the region.

European osteoarthritis therapeutics market was valued at $3,304.0 million in 2025 and is projected to reach $7,052.1 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026–2035). Increased regulatory approvals of osteoarthritis therapies by European manufacturers are a key driver for growth in the market, as locally developed drugs expand treatment availability and reinforce clinician confidence in therapeutic intervention. European pharmaceutical firms are actively advancing product portfolios through new molecule approvals and expanded indications, with regulatory oversight by the European Medicines Agency (EMA) ensuring safety and efficacy across member states.

European High-Performance Liquid Chromatography (HPLC) market was valued at $1,696.8 million in 2025 and is projected to reach $2462.1 million by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). Expanding pharmaceutical manufacturing and stringent quality control requirements in Europe are key drivers for this market in the region. The European Medicines Agency (EMA) and national competent authorities enforce rigorous Good Manufacturing Practice (GMP) standards to ensure that pharmaceutical products consistently meet predefined quality, safety, and efficacy criteria before they reach patients.

BRICS e-commerce logistics market was valued at $183.3 billion in 2025 and is projected to reach $525.2 billion by 2035, growing at a CAGR of 12.4% during the forecast period (2026–2035). The rapid acceleration of mobile-led e-commerce adoption across BRICS markets, particularly India, is directly strengthening demand in the BRICS e-commerce logistics market by driving higher order volumes and delivery frequency. Analysis by Affle’s MAAS platform and Sensor Tower indicates sustained growth in daily active users on shopping apps in India, with the top 10 platforms averaging over 7 million daily active users each in Q2 2021, reflecting an 18% year-on-year increase. This expansion in user engagement translates into a consistent rise in transaction volumes, requiring scalable logistics capabilities across last-mile delivery, warehousing, and order fulfillment.

European healthcare contract development and manufacturing organization (CDMO) market was valued at $45.6 billion in 2025 and is growing at a CAGR of 4.9% during the forecast period (2026-2035). The European healthcare contract development and manufacturing organization (CDMO) market is experiencing steady growth as pharmaceutical and biotechnology companies increasingly rely on specialized partners to streamline development and manufacturing processes. Rising demand for biologics, advanced therapies, and complex small-molecule drugs is driving outsourcing to CDMOs with strong regulatory expertise and scalable capabilities. Companies are focusing on integrated service models that cover development, analytical testing, and commercial manufacturing to reduce time-to-market and ensure compliance with stringent European regulations. Technological adoption, including automation, digital quality systems, and advanced process monitoring, is improving efficiency and consistency across production stages. Regional CDMOs are also investing in capacity expansion and facility modernization to accommodate diverse therapeutic portfolios. Collectively, these trends indicate a market shaped by innovation, operational resilience, and increasing strategic partnerships.